Pancreatic cancer drug improves lifespan

December 10, 2012

By Flinn Foundation

From: Arizona Republic

A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to the results of a new trial led by physicians from Scottsdale Healthcare’s Virginia G. Cancer Center Clinical Trials and Translational Genomics Research Institute.

Read More: Cancer drug fares well in trial